ABOUT US
Affacare Medical (Beijing) Co., Ltd.
Dedicated to building the company into a surgical instrument platform company
Beijing Affacare Medical Co., Ltd., founded in 2012, was the first high-tech enterprise in China to achieve the domestic production of surgical ultrasonic scalpels. The company pioneered the "One Patient, One Scalpel" usage concept, driving the industry's shift toward single-use ultrasonic scalpels.
Since its establishment, Affacare has focused on the R&D, manufacturing, and sales of minimally invasive surgical products, including ultrasonic scalpels and ultrasonic pneumatic lithotripsy systems. The company is dedicated to reducing healthcare costs through technological innovation, making high-quality surgical instruments more accessible.
With over 70 patents, Affacare’s self-developed ultrasonic surgical system meets the advanced standards of international counterparts and has been selected for the Excellent Domestic Medical Device Product Catalog. The company holds certifications including GMP, ISO 13485, and MDSAP, along with regulatory approvals from NMPA, CE, and others. Its products serve more than 1,800 medical institutions across China and have been used in over one million surgical procedures.
Looking ahead, Affacare remains committed to its mission: “Dedicated to Every Surgery.” The company plans to expand its product portfolio to include energy platforms, endoscopic consumables, and tumor ablation solutions, while continuing to deepen its expertise in minimally invasive surgery and accelerate global expansion—striving to become a trusted surgical partner for surgeons worldwide.
Clinical surgical application
Existing employees
National patent
Serve medical institutions
Clinical surgical application
Global Business Expansion Countries
Corporate culture
In the future, Affacare will take "serving every surgery with dedication" as its mission, expand its product lines—including energy platforms, endoscopic consumables, and tumor ablation—and continue to deepen its expertise in minimally invasive surgery. We will accelerate our global expansion and become a trusted surgical partner for surgeons.
Responsibility
Advocate for and practice "one person, one knife, one discard."
It is the company’s responsibility to society.
Unity
Employees work together in unity.
Joint Struggle
Persistence
We are relentlessly striving to build the company into an outstanding platform enterprise for surgical medical devices.
Achievement
Fully leverage the talents and wisdom of employees.
Build the company's brand
Honorary Qualifications
The company currently holds over 70 patents. Its independently developed ultrasonic surgical system has reached an advanced international standard comparable to similar products and has been included in the Catalog of Outstanding Domestically Produced Medical Devices. The products have obtained GMP, ISO 13485, and MDSAP certifications and have been approved by NMPA, CE, and other regulatory authorities. The company serves more than 1,800 medical institutions nationwide, with clinical applications exceeding 1 million surgical procedures.
Development History
Founded in 2012, the company is one of China’s earliest high-tech enterprises to achieve domestic production of surgical ultrasonic scalpels. It was also the first to introduce the “one person, one blade, one-time disposal” usage concept, thereby driving the industry’s shift toward single-use ultrasonic scalpels.